Cancer Genome Evolution Research Group, University College London Cancer Institute, London, UK.
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Nat Genet. 2020 Mar;52(3):283-293. doi: 10.1038/s41588-020-0584-7. Epub 2020 Mar 5.
Whole-genome doubling (WGD) is a prevalent event in cancer, involving a doubling of the entire chromosome complement. However, despite its prevalence and prognostic relevance, the evolutionary selection pressures for WGD in cancer have not been investigated. Here, we combine evolutionary simulations with an analysis of cancer sequencing data to explore WGD during cancer evolution. Simulations suggest that WGD can be selected to mitigate the irreversible, ratchet-like, accumulation of deleterious somatic alterations, provided that they occur at a sufficiently high rate. Consistent with this, we observe an enrichment for WGD in tumor types with extensive loss of heterozygosity, including lung squamous cell carcinoma and triple-negative breast cancers, and we find evidence for negative selection against homozygous loss of essential genes before, but not after, WGD. Finally, we demonstrate that loss of heterozygosity and temporal dissection of mutations can be exploited to identify novel tumor suppressor genes and to obtain a deeper characterization of known cancer genes.
全基因组加倍(Whole-genome doubling,WGD)是癌症中普遍存在的事件,涉及整个染色体组的加倍。然而,尽管它普遍存在且具有预后相关性,但癌症中 WGD 的进化选择压力尚未得到研究。在这里,我们结合进化模拟和癌症测序数据的分析来探索癌症进化过程中的 WGD。模拟表明,只要发生的速度足够快,WGD 就可以被选择来减轻不可逆转的、棘轮式的有害体细胞突变的积累。与这一观点一致的是,我们观察到在杂合性缺失广泛的肿瘤类型中,WGD 富集,包括肺鳞状细胞癌和三阴性乳腺癌,并且我们发现证据表明,在 WGD 之前存在针对必需基因纯合缺失的负选择,但在 WGD 之后不存在。最后,我们证明了杂合性缺失和突变的时间剖析可以被用来识别新的肿瘤抑制基因,并对已知的癌症基因进行更深入的特征描述。